Clinical Trials and Therapeutic Approaches

Clinical trials for Alzheimer’s disease are crucial in evaluating new therapeutic approaches designed to slow or halt disease progression. These trials often test innovative drugs that target amyloid-beta plaques, tau tangles, and other key pathological features of the disease. Additionally, researchers are exploring gene therapy, immunotherapy, and lifestyle interventions to enhance cognitive function and delay symptoms. Each trial aims to provide valuable insights into the efficacy and safety of new treatments, contributing to a broader understanding of how to effectively manage and ultimately cure Alzheimer’s disease.

 

    Related Conference of Clinical Trials and Therapeutic Approaches

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 16-17, 2026

    12th International Conference on Brain Injury & Neuro Surgeons

    Amsterdam, Netherlands
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore

    Clinical Trials and Therapeutic Approaches Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in